VIASKIN
"VIASKIN" is a word and design mark owned by DBV Technologies, filed at the USPTO on August 17, 2017. It was cancelled and covers classes 5, 9, 10, 16, 41, 42 and 44.
- Status
- Cancelled
- Since January 10, 2025
- Filed
- August 17, 2017
- Registered
- June 26, 2018
- Renewal due
- August 17, 2027
- Application no.
- 79219735
- Registration no.
- 5499984
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 7 classes
Who owns VIASKIN
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
What the mark covers
The products and services VIASKIN is filed for, grouped by Nice class.
Adhesive patches device for administering by cutaneous or epicutaneous means of powdered medical or pharmaceutical substances for human purposes in preventing or treating by immunotherapy; medical patch containing a preparation in powder form for delivering detection agents used for diagnosis; occlusive patch for cutaneous absorption of a powdered medicated substance used in the treatment by immunotherapy, all of the aforesaid goods only for human use
Data processing equipment, namely, computers; scientific research apparatus and instruments for laboratories for detecting allergies; downloadable computer software applications for providing information regarding immunotherapy; interfaces for computers; downloadable electronic publications in the nature of informational sheets in the field of immunotherapy
Medical instruments, apparatus and devices intended for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans; occlusive dispenser for medical use; medical instrument using the electrostatic properties of a biocompatible medium for the treatment by immunotherapy, all of the aforesaid goods only for human use
Printed publications, namely, magazines in the field of immunotherapy; posters; pamphlets in the field of immunotherapy; printed informational fliers and leaflets featuring information regarding immunotherapy; printed matter in the nature of manual handbooks in the field of immunotherapy; newspapers; booklets in the field of immunotherapy; magazine journals featuring information about immunotherapy; printed instructional or teaching material in the field of immunotherapy excluding apparatus
Education services, namely, providing training in the form of classes and seminars in the field of immunotherapy ; organization and conducting of educational colloquiums, educational conferences, and educational conventions in the field of immunotherapy; organization and conducting of non-virtual educational forums in the field of immunotherapy; provision of non-downloadable videos in the field of immunotherapy online; electronic desktop publishing; provision of non-downloadable online electronic publications; organization of exhibitions for educational purposes
Scientific research services for medical purposes in the field of immunotherapy; research in the field of immunotherapy; scientific research in the field of processing and treatment of allergies; scientific research in the nature of discovery and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; research and development of new products for others
Medical services in the nature of applying a method for desensitizing by immunotherapy; medical consultancy in the field of desensitization to combat allergies; health counseling services; health care services for treating allergies
What has happened so far
Steps recorded by the USPTO, newest first.
- New representative at ib received
- Total invalidation processed by the ib
- Total invalidation of reg ext protection sent to ib
- Invalidation processed
- Total invalidation of reg ext protection created
- Cancelled section 71
- Change of name/address rec'd from ib
- New representative at ib received
- New representative at ib received
- Final decision transaction processed by ib
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About VIASKIN
Who owns the trademark "VIASKIN"?
The USPTO trademark "VIASKIN" (application 79219735) is owned by DBV Technologies.
What is the status of "VIASKIN"?
Its status at the USPTO is: cancelled.
When was "VIASKIN" registered?
It was registered on June 26, 2018.
Get this data via the API
Everything on this page comes from the Signa API. Pull VIASKIN and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2acc-0d1b-77e1-82cf-ebb5256dbdf6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2acc-0d1b-77e1-82cf-ebb5256dbdf6",
"object": "trademark",
"mark_text": "VIASKIN",
"status": {
"primary": "inactive",
"stage": "cancelled"
},
"office_code": "US",
"application_number": "79219735",
"filing_date": "2017-08-17",
"nice_classes": [
5,
9,
10,
16,
41,
42,
44
],
"owners": [
{
"name": "DBV TECHNOLOGIES",
"entity_id": "ent_019eb706-d4df-739e-ba1d-b3581088cd30"
}
]
}